Cerebrospinal fluid biomarkers for clinical trials: why markers for differential diagnosis are important
Arch Neurol
.
2012 Nov;69(11):1407-8.
doi: 10.1001/archneurol.2012.2353.
Author
Richard J Perrin
PMID:
22926002
DOI:
10.1001/archneurol.2012.2353
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomarkers / cerebrospinal fluid*
Dementia / cerebrospinal fluid*
Dementia / diagnosis*
Female
Humans
Male
Parkinson Disease / cerebrospinal fluid*
Parkinson Disease / diagnosis*
Substances
Biomarkers
Grants and funding
P50 AG005681/AG/NIA NIH HHS/United States